About Inotiv
Inotiv: The Leading Provider of Preclinical Drug Development Services
Inotiv is a leading provider of preclinical drug development services, offering a wide range of (bio)analytical, in vivo, toxicology and molecular pathology services to support the pharmaceutical industry. With over 40 years of experience in the field, Inotiv has established itself as a trusted partner for drug developers looking to bring new therapies to market.
At Inotiv, we understand that preclinical drug development is a critical stage in the drug discovery process. It involves testing potential drugs on animals to determine their safety and efficacy before they can be tested on humans. This stage requires rigorous testing and analysis to ensure that the drugs are safe for human use and have the desired therapeutic effect.
Our team of experts at Inotiv has extensive experience in conducting preclinical studies across various therapeutic areas such as oncology, cardiovascular diseases, metabolic disorders, neurology and more. We offer customized solutions tailored to meet our clients' specific needs throughout all stages of preclinical development.
Our (bio)analytical services include method development and validation for small molecules and biologics using LC-MS/MS or ELISA platforms. Our state-of-the-art facilities are equipped with advanced instrumentation such as UPLC-MS/MS systems that enable us to provide high-quality data with fast turnaround times.
In addition to our analytical capabilities, we also offer in vivo studies using various animal models such as rodents or non-human primates. Our toxicology studies assess the safety profile of potential drugs by evaluating their effects on vital organs like liver or kidney function tests along with histopathological examination.
Molecular pathology is another area where we excel at Inotiv; it involves analyzing tissues from animals treated with test compounds using techniques like immunohistochemistry or PCR-based assays. These analyses help us understand how drugs interact with biological systems at a molecular level which can inform future drug development strategies.
At Inotiv, we pride ourselves on our commitment to quality and compliance. We adhere to strict regulatory guidelines such as GLP (Good Laboratory Practice) and GMP (Good Manufacturing Practice) to ensure that our clients receive reliable data that meets regulatory requirements.
In conclusion, Inotiv is a leading provider of preclinical drug development services with over 40 years of experience in the field. Our team of experts offers customized solutions tailored to meet our clients' specific needs throughout all stages of preclinical development. We provide (bio)analytical, in vivo, toxicology and molecular pathology services using state-of-the-art facilities equipped with advanced instrumentation. Our commitment to quality and compliance ensures that our clients receive reliable data that meets regulatory requirements. Contact us today to learn more about how we can help you bring your new therapies to market!